Current trends in the management of extra-abdominal desmoid tumours

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Papagelopoulos, Panayiotis J ^a   Mavrogenis, Andreas F ^a   Mitsiokapa, Evanthia A ^b   Papaparaskeva, Kleo Th ^c   Galanis, Evanthia C ^d   Soucacos, Panayotis N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b THRIASIO GENERAL HOSPITAL   (Greece)

^c ATHENS MEDICAL CENTER   (Greece)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIESTROGEN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GADOLINIUM; GOSERELIN; INDOMETACIN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MELOXICAM; METHOTREXATE; MITOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE; RETINOIC ACID; SULINDAC; TAMOXIFEN; TOREMIFENE; VINBLASTINE; VINCRISTINE;

ANAMNESIS; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DESMOID TUMOR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE REGIMEN; EXTERNAL BEAM RADIOTHERAPY; FASCIITIS; FIBROMA; FIBROSARCOMA; FIBROSIS; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; MYXOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RADIATION RESPONSE; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 33646735552     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-4-21     Document Type: Review

References (72)

1. Leithner A, Schnack B, Katterschafka T, Wiltschke C, Amann G, Windhager R, Kotz R, Zielinski CC: Treatment of extra-abdominal desmoid tumours with interferon-alpha with or without tretinoin. J Surg Oncol 2000, 73:21-25.
2. Spiegel DA, Dormans JP, Meyer JS, Himelstein B, Mathur S, Asada N, Womer RB: Aggressive fibromatosis from infancy to adolescence. J Pediatr Orthop 1999, 19:776-784.
3. Stout AP: Juvenile fibromatosis. Cancer 1954, 7:953-971.
4. Reitamo JJ, Scheinin TM, Hayry P: The desmoid syndrome: new aspects in the cause, pathogenesis and treatment of the desmoid tumour. Am J Surg 1986, 151:230-237.
5. Lewis JJ, Boland PJ, Leung DHY, Woodruff JM, Brennan MF: The Enigma of Desmoid Tumours. An Surg 1999, 229:866-873.
6. Sherman NE, Romsdahl M, Evans H, Zagars G, Oswald MJ: Desmoid tumours: A 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys 1990, 19:37-40.
7. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ: Increased beta catenin and somatic APC mutations in sporadic aggressive fibromatosis. Am J Pathol 1997, 151:329-334.
8. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, Wolfe HJ: Aggressive fibromatosis (desmoid tumour) is a monoclonal disorder. Am J Surg Pathol 1996, 68:194-200.
9. Li C, Bapat B, Alman BA: Adenomatous polyposis coli gene mutation alters proliferation through its beta catenin regulatory function in aggressive fibromatosis (desmoid tumour). Am J Pathol 1998, 153:709-714.
10. Muller E, Catsagnaro M, Yandel DW, Wolfe HJ, Alman BA: Molecular genetic and immunohistochemical analysis of the tumour suppressor genes Rb and p53 in palmar and aggressive fibromatosis. Am J Surg Pathol 1996, 68:194-200.
11. Hizawa K, Iida M, Mibu R, Aoyagi K, Yao T, Fujishima M: Desmoid tumours in familial adenomatous polyposis/Gardner's Syndrome. J Clin Gastroenterol 1997, 25:334-337.
12. Merchant TE, Nguyen D, Walter AW, Pappo AS, Kun LE, Rao BN: Long-term results with radiation therapy for pediatric desmoid tumours. Int J Radiat Oncol Biol Phys 2000, 47:1267-1271.
13. Li M, Cordon-Cardo C, Gerald WL, Rosai J: Desmoid fibromatosis is a clonal process. Hum Pathol 1996, 27:939-943.
14. Hajra KM, Fearon ER: Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002, 34:255-268.
15. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, Petrelli NJ: Desmoid tumours in patients with familial adenomatous polyposis. Cancer 1994, 74:1270-1274.
16. Barber HM, Galasko CSB, Woods CG: Multicentric extra-abdominal desmoid tumours: report of two cases. J Bone Joint Surg Br 1973, 55:858-863.
17. Sundaram M, Duffrin H, McGuire MH, Vas W: Synchronous multicentric desmoid tumors (aggressive fibromatosis) of the extremities. Skeletal Radiol 1988, 17:16-19.
18. Faulkner LB, Hajdu SI, Kher U, La Quaglia M, Exelby PR, Heller G, Wollner N: Pediatric desmoid tumour: retrospective analysis of 63 cases. J Clin Oncol 1995, 13:2813-2818.
19. Rao BN, Horowitz ME, Parham DM, Etcubanas EE, Fleming ID, Pratt CB, Hustu HO, Green AA, Kun LE: Challenges in the treatment of childhood fibromatosis. Arch Surg 1987, 122:1296-1298.
20. Humar A, Chou S, Carpenter B: Fibromatosis in infancy and childhood: the spectrum. J Pediatr Surg 1993, 28:1446-1450.
21. Pritchard DJ, Nascimento AG, Peterson IA: Local control of extra-abdominal desmoid tumours. J Bone Joint Surg Am 1996, 78:848-854.
22. Posner MC, Shiu MH, Newsome JL, Hadju SI, Gaynor JJ, Brennan MF: The desmoid tumour: not a benign disease. Arch Surg 1989, 124:191-196.
23. Sweis IE, McHenry CR, Jordan RB: Limb and life threatening desmoid tumour of the neck. Plast Reconstr Surg 1993, 92:335-339.
24. Weiss SW, Goldblum JR: Fibromatoses. In Enzinger and Weiss's Soft Tissue Tumors 4th edition. Edited by: Weiss SW, Goldblum JR. Mosby St Louis; 2001:309-346.
25. Liu P, Thorner P: MRI of fibromatosis with pathologic correlation. Pediatr Radiol 1992, 22:587-589.
26. van Kints MJ, Tjon RTO, Tham TA, Vroegindeweij D, van Erp AJ: Magnetic resonance imaging findings in aggressive fibromatosis. Eur J Radiol 1993, 16:230-232.
27. O'Keefe F, Kim EE, Wallace S: Magnetic resonance imaging in aggressive fibromatosis. Clin Radiol 1990, 42:170-173.
28. Enzinger FM, Shiraki M: Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid): analysis of 30 cases followed-up for 10 or more years. Cancer 1967, 21:1131.
29. Goellner JR, Soule EH: Desmoid tumors: an ultrastructural study of eight cases. Hum Pathol 1980, 11:43.
30. Bohm P, Krober S, Greschniok A, et al.: Desmoplastic fibroma of the bone: a report of two patients, review of the literature and therapeutic implications. Cancer 1996, 78:1011.
31. Acker JC, Bossen EH, Halperin EC: The management of desmoid tumours. Int J Radiat Oncol Biol Phys 1993, 26:851-858.
32. Bauernhofer T, Stoger N, Schmid M, Smola M, Gurtl-Lackner B, Hofler G, Ranner G, Reisinger E, Samonigg H: Sequential treatment of recurrent mesenteric desmoid tumour. Cancer 1996, 77:1061-1065.
33. Enneking WF, Spanier SS: A system for the surgical staging of musculoskeletal sarcomas. In Clinical trends in orthopaedics Edited by: Straub LR, Wilson PD Jr. New York: Thieme-Stratton; 1982:125-33.
34. Fernberg JO, Broslo O, Larsson O, Soderlund V, Strander H: Interferon-induced remission in aggressive fibromatosis of the lower extremity. Acta Oncol 1999, 38:971-972.
35. Geurs F, Kok TC: Regression of a great abdominal desmoid tumour by interferon alpha. J Clin Gastroenterol 1993, 16:264-265.
36. Waddell WR, Gerner RE, Reich MP: Nonsteroid anti-inflammatory drugs and tamoxifen for desmoid tumours and carcinoma of the stomach. J Surg Oncol 1983, 22:197-211.
37. 1 for unresectable desmoid tumours. Am J Surg 1991, 161:416-421.
38. Wilcken N, Tattersall MH: Endocrine therapy for desmoid tumours. Cancer 1991, 68:1384-1388.
39. Abbas AE, Deschamps C, Cassivi SD, Nichols FC 3rd, Allen MS, Schleck CD, Pairolero PC: Chest-wall desmoid tumours: results of surgical intervention. Ann Thorac Surg 2004, 78:1219-1223.
40. Lackner H, Urban C, Benesch M, Raith J, Moser A, Sovinz P, Schwinger W, Dornbusch HJ, Triebl-Roth K: Multimodal treatment of children with unresectable or recurrent desmoid tumours: an 11-year longitudinal observational study. J Pediatr Hematol Oncol 2004, 26:518-522.
41. Yildiz F, Kars A, Cengiz M, Yildiz O, Akyurek S, Selek U, Ozyigit G, Atahan IL: 1,25-Dihydroxy vitamin D3: can it be an effective therapeutic option for aggressive fibromatosis. Med Hypotheses 2005, 64:333-336.
42. Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT: The role of adjuvant radiotherapy in the treatment of resectable desmoid tumours. Int J Radiat Oncol Biol Phys 1997, 39:659-665.
43. Overhaus M, Decker P, Fischer HP, Textor HJ, Hirner A: Desmoid tumours of the abdominal wall: A case report. World J Surg Oncol 2003, 1:11.
44. Duggal A, Dickinson IC, Sommerville S, Gallie P: The management of extra-abdominal desmoid tumours. Int Orthop 2004, 28:252-256.
45. Easter DW, Halasz NA: Recent trends in the management of desmoid tumours. Summary of 19 cases and review of the literature. Ann Surg .1989, 210:765-769.
46. Leibel SA, Wara WM, Hill DR, Bovill EG Jr, de Lorimier AA, Beckstead JH, Phillips TL: Desmoid tumours: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys 1983, 9:1167-1171.
47. Kiel KD, Suit HD: Radiation therapy in the treatment of aggressive fibromatosis (desmoid tumours). Cancer 1984, 54:2051-2055.
48. Mirabell R, Suit HD, Mankin HJ, Zuckerberg LR, Stracher MA, Rosenberg AE: Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1990, 18:535-540.
49. Okuno SH, Edmonson JH: Combination chemotherapy for desmoid tumours. Cancer 2003, 97:1134-1135.
50. Bataini JP, Belloir C, Mazabraud A, Pilleron JP, Cartigny A, Jaulerry C, Ghossein NA. Desmoid tumours in adults: the role of radiotherapy in their management. Am J Surg 1988, 155:754-760.
51. Karakousis CP, Mayordomo J, Zografos GC, Driscoll DL: Desmoid tumours of the trunk and extremity. Cancer 1993, 72:1637-1641.
52. Raney RB Jr, Evans A, Granowetter L, Schnaufer L, Uri A, Littman P: Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics 1987, 79:394-398.
53. Raney RB Jr: Chemotherapy for children with aggressive fibromatosis and Langerhan's cell histiocytosis. Clin Orthop 1991, 262:58-63.
54. Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, Rosenberg AE, Efird JT, Suit HD: Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 1998, 40:637-45.
55. Zelefsky MJ, Harrison LB, Shiu MH, Armstrong JG, Haidu SI, Brennan MF: Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumours. Cancer 1991, 67:380-4.
56. Fong Y, Rosen PP, Brennan MF: Multifocal desmoids. Surgery 1993, 114:902-906.
57. Lim CL, Walker MJ, Mehta RR, Das GT. Oestrogen and antioestrogen binding sites in desmoid tumours. Eur J Cancer Clin Oncol 1986, 22:583-587.
58. Caldwell EH: Desmoid tumour: musculoaponeurotic fibrosis of the abdominal wall. Surgery 1976, 79:104-106.
59. Kinzbrunner B, Ritter S, Domingo J, Rosenthal CJ: Remission of rapidly growing desmoid tumours after tamoxifen therapy. Cancer 1983, 52:2201-2204.
60. Klein WA, Miller HH, Anderson M, DeCosse JJ: Use of indomethacin, suldinac, and tamoxifen for the treatment of desmoid tumours associated with familial pollyposis. Cancer 1987, 60:2863-2868.
61. Izes JK, Zinman LN, Larsen CR. Regression of large pelvic desmoid tumour by tamoxifen and sulindac. Urology 1996, 47:756-759.
62. Raguse JD, Gath HJ, Oettle H, Bier J: Interferon-induced remission of rapidly growing aggressive fibromatosis in the temporal fossa. Int J Oral Maxillofac Surg 2004, 33:606-609.
63. Grande'r D, Einhorn S: Interferon and malignant disease - how does it work and why doesn't it always? Acta Oncol 1998, 37:331-338.
64. Hardell L, Breivald M, Hennerdal S, Fernberg JO, Strander H: Shrinkage of desmoid tumor with interferon alfa treatment: a case report. Cytokines Cell Mol Ther 2000, 6:155-156.
65. Stuart-Harris R, Penny R, eds: Clinical applications of the interferons. London: Chapman & Hall Medical; 1997.
66. Goepfert H, Cangir A, Ayala AG, Eftekhari F: Chemotherapy of locally aggressive head and neck tumors in the pediatric age group: desmoid fibromatosis and nasopharyngeal angiofibroma. Am J Surg 1982, 144:437-444.
67. Sportiello DJ, Hoogerland DL: A recurrent pelvic desmoid tumour successfully treated with tamoxifen. Cancer 1991, 67:1443-1446.
68. Lewis JJ, Benedetti F: Adjuvant therapy for soft tissue sarcomas. Surg Oncol Clin N Am 1997, 6:847-862.
69. Schnitzler M, Cohen Z, Blackstein M, Berk T, Gallinger S, Madlensky L, McLeod R: Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum 1997, 40:798-801.
70. Skapek SX, Hawk BJ, Hoffer FA, Dahl GV, Granowetter L, Gebhardt MC, Ferguson WS, Grier HE: Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumour in children. J Clin Oncol 1998, 16:3021-3027.
71. Azzarelli A, Gronchi A, Bertulli R, Tesoro JD, Baratti D, Pennacchioli E, Dileo P, Rasponi A, Ferrari A, Pilotti S, Casali PG: Low-dose chemotherapy with methotrexate, and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001, 92:1259-1264.
72. Gega M, Yanagi H, Yoshikawa R, Noda M, Ikeuchi H, Tsukamoto, K, Oshima T, Fujiwara Y, Gondo N, Tamura K, Utsunomiya J, Hashimoto-Tamaoki T, Yamamura T: Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 2006, 24:102-105.